Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs Ondra Health

Belle Health
Graded #48

Lower grade

vs+9.799999999999997
Ondra Health
Graded #12

Higher grade

The verdict

Ondra Health takes it — 86.8/100 to 77/100.

Ondra Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lowest semaglutide sticker on the board ($93) paired with some brand-name access and LegitScript verification.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +1
92
91
Dose & formulationOndra Health +12
72
84
Clinical oversightOndra Health +15
71
86
Labs & monitoringOndra Health +12
72
84
FulfillmentOndra Health +3
85
88
Contract termsOndra Health +31
55
86
Belle Health · left barOndra Health · right bar

The numbers

MetricBelle HealthOndra Health
WeighScore77/10086.8/100
GradeC+B
Scorecard rank#48#12
Semaglutide$119/mo$93/mo
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$166/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
Ondra Health

Graded #12 · B

Strengths

  • Lowest listed semaglutide price ($93/mo)
  • Some brand-name access
  • LegitScript-verified, all 50 states

Where it loses points

  • Tirzepatide steps up to $166/mo
  • Labs/monitoring detail not published
  • Compounded-first

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard